CAS: 5448-43-1; 6-Chloroquinoxaline

相似化合物

18671-97-1 62163-09-1 1932-67-8

上下游产品

CAS号107-21-1 乙二醇 | CAS号95-83-0 4-氯邻苯二胺 | CAS号517-21-5 乙二醛亚硫酸氢钠水合物 | CAS号6935-29-1 喹喔啉1-氧化物 | CAS号151-50-8 氰化钾 | CAS号89-63-4 邻硝基对氯苯胺 | CAS号7677-24-9 三甲基氰硅烷 | CAS号2958-87-4 2,3,6-三氯喹喔啉 | CAS号6639-79-8 2,3-二羟基-6-氯喹喔啉 | CAS号39267-11-3 6-chloro-quinox... | CAS号6639-80-1 Quinoxaline, 6-... | CAS号23088-24-6 6-喹喔啉甲腈 | CAS号73855-45-5 6-氯-1,2,3,4-四氢-喹噁啉 | CAS号7467-91-6 6-羟基喹喔啉

📜(4-Chloro-Phenyl)-[2-(Phenyl-Hydrazono)-Eth-(E)-Ylidene]-Amine 650.0 °C,1.33 Pa 条件下,反应 1.5H,反应生成 6-氯喹喔啉
参考文献:Mcnab,Hamish,Journal Of The Chemical Society. Perkin Transactions I,1982,# 8,P. 1941-1946
标题:Mcnab,Hamish,Journal Of The Chemical Society. Perkin Transactions I,1982,# 8,P. 1941-1946

专利信息

专利号:US-6472534-B2
优先权日:1999-10-21
标 题:Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
发明人：BORER BENNETT C; ZOOK SCOTT E; BUSSE JULIETTE K
权利人:AGOURON PHARMA
摘要:Methods for the preparation of chemical intermediates in the synthesis of HIV-protease inhibitors related to and including nelfinavir mesylate are disclosed. The method of this invention comprises converting tetrohydran derivatives into oxazolines to provide key reaction intermediates for the preparation of nelfinavir. Also disclosed is a method for the preparation of a chiral amino alcohol from an epoxy-tetrahydrofuran.

专利号:US-2002038033-A1
优先权日:1999-10-21
标题:Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors

专利号:US-2003023092-A1
优先权日:1999-10-21
标题 :Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors

专利号:US-6403799-B1
优先权日:1999-10-21
标题:Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors

专利号:CN-107460497-A
优先权日:2017-07-07
标 题 :Electrochemical catalytic synthesis of acyl-substituted electron-deficient nitrogen-containing heterocyclic compounds

专利号:US-5846993-A
优先权日:1992-12-22
标题:HIV protease inhibitors
发明人：DRESSMAN BRUCE A; FRITZ JAMES E; KALDOR STEPHEN W; KALISH VINCENT J; REICH SIEGFRIED HEINZ; TATLOCK JOHN H; RODRIGUEZ MICHAEL J
权利人:AGOURON PHARMA
摘要:HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.